Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-06-08Clinical Trial Update: Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer [Phase 2]
Phase II study evaluating carboplatin and pemetrexed with or without OGX-427 in untreated stage IV non-squamous non-small cell lung cancer h…
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation [Phase 2]
Phase 2 trial comparing intermittent and maintenance icotinib in combination with pemetrexed/carboplatin versus icotinib alone in EGFR-mutan…
-
CLINICAL_TRIALS trial_result · 2018-06-01Clinical Trial Update: A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before [Phase 2]
Phase 2 study evaluating Cixutumumab (IMC-A12) with or without standard chemotherapies in patients with treatment-naive non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2018-05-31Clinical Trial Update: Personalized DC Vaccine for Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating a personalized dendritic cell vaccine for non-small-cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Anti-CTLA-4 Antibody Followed by Anti-PD-1 Antibody in Recurrent or Metastatic NSCLC [Phase 1]
Phase 1 clinical trial update evaluating sequential anti-CTLA-4 antibody followed by anti-PD-1 antibody in recurrent or metastatic non-small…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer [Phase 1]
A Phase I trial of hypofractionated stereotactic boost radiotherapy for non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations [Phase 1, Phase 2]
Pfizer studied lorlatinib (PF-06463922), an ALK/ROS1 inhibitor, in patients with advanced non-small cell lung cancer harboring ALK or ROS1 a…
-
CLINICAL_TRIALS trial_result · 2018-05-23Clinical Trial Update: The Jules Bordet Institute Molecular Profiling Program Feasibility Trial [NA]
Feasibility trial update from the Jules Bordet Institute molecular profiling program; the study has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating circulating T cells and tumor-infiltrating lymphocytes during/after pre-surgery chemotherapy in non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients
This clinical trial update reports on the effectiveness and safety of surgical interventions in elderly patients with non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer
An observational study investigating the clinical characteristics of patients with T1 non-small cell lung cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer
A completed clinical trial evaluating the effectiveness of sublobar dissection in patients with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: A Study in Non Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial in non-small cell lung cancer sponsored by Eli Lilly has completed, with results posted on May 18, 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating vinorelbine tartrate and paclitaxel in older patients with advanced non-small cell lung cancer has completed with…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update reports the termination of a Phase 1/2 study evaluating MLN8237 in combination with erlotinib for non-small cell …
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Study of PX-866 and Docetaxel in Solid Tumors [Phase 1, Phase 2]
This clinical trial update notes the completion of a Phase 1/2 study of PX-866 with docetaxel in solid tumors, including non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC [Phase 1, Phase 2]
An early-phase clinical trial evaluating anti-MUC1 CAR T cells in combination with PD-1 knockout engineered T cells for non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]
A Phase 2 safety and efficacy study evaluating the combination of CC-486 (oral azacitidine) with MK-3475 (pembrolizumab) in locally advanced…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical Practice
An observational, real-world study evaluating Avastin (bevacizumab) in elderly patients with non-squamous non-small cell lung cancer. The st…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung [NA]
Phase II study update on stereotactic body radiation therapy using Tomotherapy for lung tumors; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Lung Stereotactic Body Radiotherapy (SBRT) Delivered Over 4 Days Versus 11 Days [NA]
A completed trial compared delivering lung SBRT over 4 days with delivery over 11 days in patients with peripheral stage I non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer [Phase 1]
A Phase 1 clinical trial evaluating autologous immune killer cells in patients with late-stage non-small cell lung cancer and hepatocellular…
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease [Phase 2]
Phase 2 trial update for advanced non-small cell lung cancer progressing after prior therapy; study terminated with posted results in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC) [Phase 2]
Phase 2 trial evaluating metformin and carbohydrate restriction in combination with platinum-based chemotherapy for stage IIIB/IV non-squamo…
-
CLINICAL_TRIALS trial_result · 2018-05-03Clinical Trial Update: Concomitant Radio-chemotherapy in the Elderly [Phase 2]
A Phase 2 trial evaluating concomitant radiotherapy and chemotherapy in elderly patients with non-small cell lung cancer has completed.